These reports and our findings suggest that NAMPT overexpression in cancer cells may lead to resistance to other chemotherapeutic agents in addition to olaparib, necessitating the future development of therapeutic strategies to overcome multi-drug resistance. Here, NAMPT is linked to cancer.